NCT07323602

Brief Summary

This study aims to investigate whether preoperative gait characteristics, measured by wearable sensors, can predict the clinical outcomes of Deep Brain Stimulation (DBS) in patients with dystonia. Participants scheduled for DBS surgery will undergo gait analysis using wearable sensors before the procedure. Clinical assessments, including the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the SF-36 Health Survey, will be conducted preoperatively and postoperatively to evaluate surgical efficacy and quality of life. The study seeks to identify gait biomarkers that correlate with optimal DBS response.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
44mo left

Started Aug 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Aug 2025Dec 2029

Study Start

First participant enrolled

August 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

January 7, 2026

Status Verified

November 1, 2025

Enrollment Period

4.3 years

First QC Date

December 22, 2025

Last Update Submit

December 22, 2025

Conditions

Keywords

dystoniadeep brain stimulationwearable Gait Analysis

Outcome Measures

Primary Outcomes (1)

  • Correlation between Baseline Gait Features and BFMDRS Improvement

    Through study completion, up to 6 months

Secondary Outcomes (3)

  • Change in Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) Score

    Baseline (pre-operative) and 6 months post-operative

  • Change in SF-36 Quality of Life Score

    Baseline (pre-operative) and 6 months post-operative

  • Gait Characteristics (Spatio-temporal parameters)

    Baseline (pre-operative)

Interventions

Patients will wear inertial measurement units (IMUs) on \[specify body parts, e.g., lower back, ankles\] to record gait data during standardized walking tasks before surgery.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of patients clinically diagnosed with isolated dystonia who are candidates for Deep Brain Stimulation (DBS) surgery at Ruijin Hospital. These participants have motor symptoms that are refractory to optimal medical therapy and are scheduled for elective surgical intervention.

You may qualify if:

  • Clinically diagnosed with primary or isolated dystonia.
  • Scheduled to undergo bilateral Deep Brain Stimulation (DBS) surgery.
  • Able to walk independently or with assistance (sufficient to perform gait analysis).
  • Willing to participate and sign informed consent.

You may not qualify if:

  • History of other neurological disorders affecting gait (e.g., stroke, severe neuropathy).
  • Significant orthopedic issues preventing gait assessment.
  • Cognitive impairment preventing cooperation with study procedures.
  • Previous functional neurosurgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, China

RECRUITING

MeSH Terms

Conditions

Dystonia

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 7, 2026

Study Start

August 1, 2025

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

January 7, 2026

Record last verified: 2025-11

Locations